Annual Report Filed on Form 20-F with SEC

Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) has announced that it has filed its Annual Report on Form 20-F containing audited consolidated financial
statements for the year ended June 30, 2017 with the US Securities and Exchange Commission.
The annual report is available on the Prana website (alterity-therapeutics.adrianbeyerle.com). Shareholders may receive a hard copy of the annual report free of charge upon request.

Contacts:
Investor Relations
Rebecca Wilson
E: rwilson@buchanwe.com.au
Tp: +61 3 9866 4722